HORIZON-HLTH-2023-DISEASE-03-18
HORIZON-HLTH-2023-DISEASE-03-18
Programme: Horizon Europe
5 projects · €37,189,782 total EU contribution (project-level) · 40 participating organizations · 18 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€37,189,782
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (6)
- Germany (5)
- France (5)
- US (4)
- DK (3)
- SE (3)
- Netherlands (2)
- UK (2)
- BE (1)
- BG (1)
- GA (1)
- IN (1)
- Italy (1)
- KH (1)
- KR (1)
- NO (1)
- PT (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Development of novel viral vectored vaccines against Marburgviruses inducing robust and cross-reactive protection MARVAX · 101137183 | HORIZON | €7,439,560 | €1,730,506 | Details |
Development and characterization of a pan-flavivirus vaccine candidate FLAVIVACCINE · 101137006 | HORIZON | €8,269,919 | €0 | Details |
Limiting West Nile Virus impact by novel vaccines and therapeutics approaches LWNVIVAT · 101137248 | HORIZON | €5,772,466 | €442,500 | Details |
Crimean-Congo Haemorrhagic Fever Vaccine and Immunotherapy CCHFVACIM · 101137033 | HORIZON | €7,755,341 | €1,593,300 | Details |
PROTECTION FROM VIRUSES WITH EPIDEMIC AND PANDEMIC DISEASE OUTBREAK POTENTIAL THROUGH DEVELOPMENT AND CLINICAL TESTING OF A NOVEL CAPSID VIRUS LIKE PARTICLE (CVLP) VACCINE VICI-DISEASE · 101136281 | HORIZON | €7,952,496 | €0 | Details |